MARCELLUSI, ANDREA
MARCELLUSI, ANDREA
Dipartimento di Scienze Farmaceutiche
Burden of Disease of Breast Cancer in Italy: A Real-World Data Analysis.
2025 F. Mennini, A. Marcellusi, P. Sciattella, M. Scortichini, A. Ragonese, F. Cattel, R. D'Antona, L. Del Mastro, S. Gori, G. Perrone, R. Migliorini, M. Trabucco Aurilio
Long-Term Effects of Direct-Acting Antivirals on Hepatitis C: Trends in Liver Disease-Related Hospitalisations in Italy
2025 F. Mennini, P. Sciattella, C. Simonelli, A. Marcellusi, S. Rosato, L. Kondili
Cost-Estimation Model of Prevented Recurrences with Atezolizumab in Early Non-Small-Cell Lung Cancer in Italy
2025 A. Marcellusi, M. Belfiore, R. Tempre, M. Buonfiglio, A. Russo
Screening strategy to advance HCV elimination in Italy: a cost-consequence analysis
2024 A. Marcellusi, F. Mennini, M. Andreoni, L. Kondili
The economic burden of asthma in Italy: evaluating the potential impact of different treatments in adult patients with severe eosinophilic asthma
2024 M. Scortichini, F. Mennini, A. Marcellusi, M. Paoletti, C. Tomino, P. Sciattella
Cost-Effectiveness Analysis of Newborn Screening for Spinal Muscular Atrophy in Italy.
2024 G. Ghetti, F. Mennini, A. Marcellusi, M. Bischof, G. Pistillo, M. Pane
Health and Economic Outcomes of Pembrolizumab in the Treatment of Metastatic Non-small Cell Lung Cancer (mNSCLC) and Melanoma in Italy.
2024 M. Paoletti, C. Bini, A. Marcellusi, F. Mennini
An Analysis of the Distribution of Direct Cost of Diabetes Care in Selected Districts in Italy
2024 F. Mennini, P. Sciattella, A. Marcellusi, F. Bartolini, F. Bernardi, F. Levrat-Guillen, M. Cozzolino, M. Di Gennaro, R. Giordana, M. Giustozzi, U. Trama
High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma
2024 J. Pöhlmann, M. Weller, A. Marcellusi, K. Grabe-Heyne, L. Krott-Coi, S. Rabar, R. Pollock
Impact of Chronic Coronary Artery Disease and Revascularization Strategy in Patients with Severe Aortic Stenosis Who Underwent Transcatheter Aortic Valve Implantation
2023 C. Aurigemma, M. Massussi, C. Fraccaro, M. Adamo, P. D'Errigo, S. Rosato, F. Seccareccia, G. Santoro, M. Baiocchi, M. Barbanti, F. Biancari, G. Baglio, A. Marcellusi, C. Trani, G. Tarantini
Hospital resource utilisation from HPV-related diseases in England: a real-world cost analysis
2023 G. Fabiano, A. Marcellusi, F.S. Mennini, P. Sciattella, G. Favato
Financial Burden of Transcatheter Aortic Valve Implantation
2023 P. D'Errigo, A. Marcellusi, F. Biancari, M. Barbanti, F. Cerza, G. Tarantini, M. Ranucci, G. Ussia, G. Costa, G. Badoni, C. Fraccaro, F. Meucci, G. Baglio, F. Seccareccia, C. Tamburino, S. Rosato
Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling Analysis
2022 A. Marcellusi, C. Simonelli, F. Mennini, L. Kondili
One-Year Outcomes and Trends over Two Eras of Transcatheter Aortic Valve Implantation in Real-World Practice
2022 G. Costa, P. D'Errigo, S. Rosato, F. Biancari, A. Marcellusi, G. Tarantini, G. Santoro, M. Baiocchi, D. Maffeo, C. Fiorina, F. Cerza, G. Baglio, T. Juvonen, G. Badoni, R. Valvo, F. Seccareccia, M. Barbanti, C. Tamburino
HPV Vaccination during the COVID-19 Pandemic in Italy: Opportunity Loss or Incremental Cost
2022 F. Mennini, A. Silenzi, A. Marcellusi, M. Conversano, A. Siddu, G. Rezza
Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation
2022 A. Marcellusi, F. Mennini, M. Ruf, C. Galli, A. Aghemo, M. Brunetto, S. Babudieri, A. Craxi, M. Andreoni, L. Kondili
The Impact of COVID-19 Vaccination on the Italian Healthcare System: A Scenario Analysis
2022 A. Marcellusi, G. Fabiano, P. Sciattella, M. Andreoni, F.S. Mennini
One-Year Outcomes after Surgical versus Transcatheter Aortic Valve Replacement with Newer Generation Devices
2021 S. Rosato, F. Biancari, P. D'Errigo, M. Barbanti, G. Tarantini, F. Bedogni, M. Ranucci, G. Costa, T. Juvonen, G. Ussia, A. Marcellusi, G. Baglio, S. Cicala, G. Badoni, F. Seccareccia, C. Tamburino
Analisi dei costi associati ai pazienti con diabete di tipo 2 a rischio di malattia cardiovascolare aterosclerotica o con malattia cardiovascolare aterosclerotica accertata = Economic burden of diabetic patients with established atherosclerotic cardiovascular disease or risk factors for atherosclerotic cardiovascular disease
2021 A. Marcellusi, P. Sciattella, C. Bini, M. Rotundo, G. Aimaretti, F. Mennini
Cross-regional variations of Covid-19 mortality in Italy: an ecological study
2021 C. Oliva, F. Di Maddaloni, A. Marcellusi, G. Favato